Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development.
Sokchea KhouAlexandra PopaCarmelo LuciFranck BihlAida Meghraoui-KheddarPierre BourdelyEmie SalavagioneEstelle CossonAlain RubodJulie CazarethPascal BarbryBernard MariRoger RezzonicoFabienne AnjuèreVeronique M BraudPublished in: Cancers (2020)
Cutaneous squamous cell carcinoma (cSCC) development has been linked to immune dysfunctions but the mechanisms are still unclear. Here, we report a progressive infiltration of tumor-associated neutrophils (TANs) in precancerous and established cSCC lesions from chemically induced skin carcinogenesis. Comparative in-depth gene expression analyses identified a predominant protumor gene expression signature of TANs in lesions compared to their respective surrounding skin. In addition, in vivo depletion of neutrophils delayed tumor growth and significantly increased the frequency of proliferating IFN-γ (interferon-γ)-producing CD8+ T cells. Mechanisms that limited antitumor responses involved high arginase activity, production of reactive oxygen species (ROS) and nitrite (NO), and the expression of programmed death-ligand 1 (PD-L1) on TAN, concomitantly with an induction of PD-1 on CD8+ T cells, which correlated with tumor size. Our data highlight the relevance of targeting neutrophils and PD-L1-PD-1 (programmed death-1) interaction in the treatment of cSCC.
Keyphrases
- gene expression
- squamous cell carcinoma
- reactive oxygen species
- dna methylation
- dendritic cells
- poor prognosis
- multiple sclerosis
- soft tissue
- immune response
- locally advanced
- lymph node metastasis
- cell death
- optical coherence tomography
- high glucose
- big data
- cancer therapy
- binding protein
- drug delivery
- machine learning
- drug induced
- rectal cancer